Coomeva Entidad Promotora de Salud S.A.

BVC:COOMEVAEPS Stock Report

Market Cap: Col$125.4b

Coomeva Entidad Promotora de Salud Past Earnings Performance

Past criteria checks 0/6

Coomeva Entidad Promotora de Salud's earnings have been declining at an average annual rate of -46.8%, while the Healthcare industry saw earnings growing at 11.6% annually. Revenues have been declining at an average rate of 8.4% per year.

Key information

-46.8%

Earnings growth rate

-36.8%

EPS growth rate

Healthcare Industry Growth13.4%
Revenue growth rate-8.4%
Return on equityn/a
Net Margin-7.8%
Last Earnings Update30 Sep 2021

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Coomeva Entidad Promotora de Salud makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BVC:COOMEVAEPS Revenue, expenses and earnings (COP Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 212,295,677-178,371112,3290
30 Jun 212,353,587-82,635110,8930
31 Mar 212,433,785-26,698107,3550
31 Dec 202,450,410-32,263113,5700
30 Sep 202,475,68610,998133,9970
30 Jun 202,574,119-35,215140,3420
31 Mar 202,809,829-61,687151,7600
31 Dec 192,756,457-58,916153,9830
30 Sep 192,907,612-46,471142,4520
30 Jun 192,975,42913,588147,5060
31 Mar 192,896,235-6,853154,0290
31 Dec 182,976,8778,472157,5920
30 Sep 183,106,5078,297169,2210
30 Jun 183,169,624-24,273171,4500
31 Mar 183,212,034-7,835172,2300
31 Dec 173,285,491-19,461174,2970
30 Sep 173,288,48823,276166,9640
30 Jun 173,359,315-20,102165,8980
31 Mar 173,406,493-8,562163,4120
31 Dec 163,448,108-12,589161,7960
30 Sep 163,470,513-19,35892,7860
30 Jun 163,378,964-29,400114,4100
31 Mar 163,386,5721,590143,6020
31 Dec 153,245,468-51,449168,7330

Quality Earnings: COOMEVAEPS is currently unprofitable.

Growing Profit Margin: COOMEVAEPS is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: COOMEVAEPS is unprofitable, and losses have increased over the past 5 years at a rate of 46.8% per year.

Accelerating Growth: Unable to compare COOMEVAEPS's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: COOMEVAEPS is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (2.2%).


Return on Equity

High ROE: COOMEVAEPS's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies